| Literature DB >> 29051431 |
Kingsley C Kanu1, Solomon N Ijioma2, Odudu Atiata3.
Abstract
The indiscriminate use of pesticide is a treat to non-target organisms. This study evaluates the haematological and biochemical changes induced by inhalation of local Nigerian dichlorvos insecticide on rats. The rats were randomly assigned to a control group which received only food and water and a test group which, in addition to food and water, was exposed to the pesticide for a period of 4 h daily for 28 days, after which exposure was discontinued for seven days. Five animals were sacrificed from each group on days 1, 7, 14, 21, 28 and 35, and blood was collected by cardiac puncture for haematological, biochemical and antioxidant analysis. Results obtained showed lowered values of red blood cell count (RBC), packed cell volume (PCV), haemoglobin, mean cell haemoglobin (MCH) and mean cell haemoglobin concentration (MCHC) (p < 0.05) with increased white blood cell count (WBC) and platelet counts after day 14 when compared to the control group. Liver enzymes aspartate amino transaminase (AST) and alanine amino transaminase (ALT) were higher in the exposed rats compared to the control group (p < 0.05). Urea and creatinine concentrations increased significantly after day 1 and at day 28, while superoxide dismutase (SOD), gluthathione (GSH) and catalase (CAT) activity increased significantly compared to the control after day 1, day 14 and day 21, respectively. The RBC, PCV and haemoglobin values of all exposed rats were restored to normal following withdrawal of the pesticide, though AST, ALT, urea, creatinine and, glutathione values remained significantly high compared to the control. Inhalation of the local insecticide is toxic to the blood, liver and kidney of laboratory rats and may be deleterious to human health following long-term exposure.Entities:
Keywords: antioxidant defense; dichlorvos toxicity; haematological alteration; hepatotoxic; renal toxicity
Year: 2016 PMID: 29051431 PMCID: PMC5606651 DOI: 10.3390/toxics4040028
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Mean haematological indices as compared to controls.
| Duration of Exposure | Sub-Group | RBC (×1012/L) | PCV (%) | Hb (g/dL) | WBC (×109/L) | Platelets Count (×109/L) |
|---|---|---|---|---|---|---|
| Day 1 | Control A | 6.33 ± 0.31 | 41.13 ± 0.58 | 12.47 ± 0.58 | 18.9 ± 1.00 | 293 ± 1.00 |
| Test A | 5.28 ± 0.14 *a+ | 34.8 ± 1.04 *a+ | 10.27 ± 0.29 *a+ | 20.13 ± 2.89 *a+ | 233.3 ± 4.04 *a+ | |
| Day 7 | Control B | 6.6 ± 0.35 | 37.67 ± 0.58 | 11.13 ± 0.12 | 5.4 ± 0.34 | 360.67 ± 0.58 |
| Test B | 6.01 ± 0.01 + | 37.2 ± 0.52 + | 11.17 ± 0.23 b+ | 6.1 ± 2.8 b+ | 415.67 ± 77.36 + | |
| Day 14 | Control C | 7.03 ± 0.02 | 41.47 ± 0.40 | 12.07 ± 0.06 | 10.8 ± 0.69 | 386.67 ± 1.16 |
| Test C | 5.63 ± 0.47 *b+ | 35.9 ± 1.56 *+ | 10.47 ± 0.06 *c+ | 14.9 ± 1.56 * | 467.33 ± 113.74 + | |
| Day 21 | Control D | 7.25 ± 0.05 | 42.34 ± 0.04 | 12.46 ± 0.05 | 12.4 ± 0.35 | 281.33 ± 1.16 |
| Test D | 6.26 ± 0.10 * | 36.85 ± 1.17 *+ | 10.42 ± 0.23 *d+ | 16.85 ± 1.87 * | 393.33 ± 25.40 * | |
| Day28 | Control E | 7.33 ± 0.017 | 44.03 ± 0.84 | 13.29 ± 0.10 | 13.46 ± 0.40 | 349.67 ± 4.5 |
| Test E | 6.45 ± 0.13 *+ | 38.93 ± 0.81 *+ | 11.23 ± 0.06 *+ | 15.13 ± 0.16 * | 391.33 ± 1.16 * | |
| Day 35 (seven days withdrawal) | Control F | 7.13 ± 0.02 | 42.12 ± 0.10 | 12.23 ± 0.12 | 18.13 ± 0.12 | 263.67 ± 1.16 |
| Test F | 7.25 ± 0.10 | 45.76 ± 1.6 | 12.84 ± 0.19 * | 21.23 ± 4.27 | 236.67 ± 28.87 |
The results are mean ± standard deviation (SD) for five rats. * significantly different compared to control (p < 0.05); within the test group, + significantly different from day 35; RBC: ‘a’ significantly different compared to day 7, 21 and 28, while ‘b’ significantly different compared to day 21 and 28; PCV: ‘a’ significantly different from day 28; Hb: ‘a’ significantly different compared to day 7 and 28, ‘b’ significant different compared to day 14 and 21, ‘c’ and ‘d’ significant different compared to day 28; WBC: ‘a’ significantly different from day 7, 14, 21 and 28, ‘b’ significant different from day 14, 21 and 28; platelet count; ‘a’ indicates significantly different from day 7, 14, 21 and 28.
Mean red blood cell indices as compared to controls.
| Duration of Exposure | Sub-group | MCV (fL) | MCH (Pg) | MCHC (g/dL) |
|---|---|---|---|---|
| Day 1 | Control A | 65.08 ± 4.09 | 19.72 ± 1.48 | 30.31 ± 1.26 |
| Test A | 65.87 ± 1.65 a | 19.43 ± 0.2 a | 29.50 ± 0.05 | |
| Day 7 | Control B | 57.20 ± 3.62 | 16.90 ± 1.02 | 29.56 ± 0.15 |
| Test B | 61.86 ± 0.98 | 18.57 ± 0.35 b | 30.03 ± 1.03 | |
| Day 14 | Control C | 59.01 ± 0.38 | 17.17 ± 0.12 | 29.10 ± 0.37 |
| Test C | 63.87 ± 2.48 b | 18.67 ± 1.59 c | 29.20 ± 1.40 | |
| Day 21 | Control D | 58.38 ± 0.33 | 17.18 ± 0.04 | 29.43 ± 0.10 |
| Test D | 58.86 ± 0.88 | 16.65 ± 0.08 * | 28.28 ± 0.28 * | |
| Day28 | Control E | 60.07 ± 1.23 | 18.13 ± 0.16 | 30.18 ± 0.35 |
| Test E | 60.33 ± 0.01 | 17.41 ± 0.45 | 28.86 ± 0.76 | |
| Day 35 (seven days withdrawal) | Control F | 59.10 ± 0.05 | 17.16 ± 0.11 | 29.04 ± 0.20 |
| Test F | 63.18 ± 3.07 | 17.72 ± 0.02 * | 28.10 ± 1.44 |
The results are mean ± SD for five rats. * Significantly different compared to control (p < 0.05); within the test group, MCV: ‘a’ significantly different compared to day 21 and 28, ‘b’ significantly different compared to day 21; MCH: ‘a’ significantly different compared to day 21 and 28, ‘b’ and ‘c’ significantly different compared to day 21.
Mean biochemical indices as compared to controls.
| Duration of Exposure | Sub-Group | AST (μ/L) | ALT (μ/L) | Urea (mg/dL) | Creatinine (mg/dL) |
|---|---|---|---|---|---|
| Day 1 | Control A | 29 ± 2.65 | 31.67 ± 4.51 | 20.28 ± 1.89 | 1.17 ± 0.09 |
| Test A | 30.33 ± 8.74 a+ | 37.67 ± 0.58 a+ | 24.4 ± 0.81 *a+ | 1.51 ± 0.09 * | |
| Day 7 | Control B | 30.67 ± 7.37 | 40.33 ± 6.66 | 23 ± 1.39 | 1.19 ± 0.17 |
| Test B | 51.67 ± 1.53 *b+ | 72 ± 5.29 * | 25.55 ± 2.37 | 1.37 ± 0.22 | |
| Day 14 | Control C | 32.33 ± 3.21 | 35 ± 1.73 | 23.83 ± 2.34 | 1.23 ± 0.03 |
| Test C | 59.33 ± 4.04 *c | 63 ± 3.0 * | 29.98 ± 5.5 | 1.25 ± 0.05 | |
| Day 21 | Control D | 36.33 ± 3.51 | 37.33 ± 1.15 | 22.27 ± 1.45 | 1.17 ± 0.07 |
| Test D | 76.33 ± 3.79 * | 64.67 ± 4.04 * | 24.55 ± 1.45 + | 1.46 ± 0.19 | |
| Day28 | Control E | 37 ± 6.25 | 32 ± 1.0 | 22.85 ± 1.28 | 1.15 ± 0.06 |
| Test E | 67.33 ± 3.06 * | 65.33 ± 5.03 * | 34.96 ± 3.46 * | 1.48 ± 0.17 * | |
| Day 35 (seven days withdrawal) | Control F | 32.67 ± 4.51 | 35.67 ± 3.21 | 22.01 ± 1.39 | 1.2 ± 0.05 |
| Test F | 66 ± 3.61 * | 63 ± 1.0 * | 35.66 ± 6.12 * | 1.56 ± 0.1 * |
* indicates significantly different compared to control (p < 0.05); within the test group + significantly different from day 35; AST: ‘a’ significantly different compared with day 7, 14, 21 and 28, ‘b’ significantly different compared to day 21 and 28, ‘c’ significantly different compared with day 21; ALT: ‘a’ significantly different compared to day 7, 14, 21 and 28; Urea: ‘a’ significantly different compared with day 28.
Figure 1Line graph of antioxidant activity in exposed rats compared to controls, data represent the mean and standard deviation of five rats, broken line indicates exposed rats while the continuous line indicates control; * indicates significant difference between exposed rats and control (p < 0.05): (a) Superoxide dismutase SOD activity (U/L), ‘a’ indicates significant difference compared to day 7, 14, 21, 28 and 35; (b) Glutathione activity (U/L), ‘a’ and ‘b’ indicate significant differences compared to day 14, 21, 28 and 35, ‘c’ and ‘d’ indicate significant differences compared to day 35 ; (c) Catalase activity (U/L), ‘a’, b’ and ‘c’ indicate significant differences compared to day 35.